Nanox (NASDAQ: NNOX) has entered into a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The announcement, made on September 11, 2026, represents Nanox's third Latin American market this year, following Argentina and Peru, and underscores the company's strategic push to broaden the reach of its affordable imaging technology in regions where access to advanced diagnostic tools is often limited.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support for the Nanox.ARC in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship positions Nanox to potentially integrate its technology into Costa Rica's public healthcare system, which could significantly enhance early disease detection and improve patient outcomes across the country. Commercialization will proceed following applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration.
The deal matters because it signals Nanox's continued execution of its global expansion strategy, particularly in Latin America, where healthcare infrastructure varies widely and access to advanced imaging can be constrained. By partnering with an established local distributor like SOLME, Nanox can navigate regulatory and operational complexities more efficiently, accelerating the adoption of its cost-effective 3D tomosynthesis system. The Nanox.ARC is designed for ease of use and scalability, making it suitable for both traditional hospital settings and alternative points of care. This aligns with Nanox's broader vision of driving the world's transition to preventive healthcare by delivering an integrated, end-to-end medical imaging and healthcare services platform.
Nanox's ecosystem combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The Nanox.ARC is a key component of this ecosystem, alongside Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
For Costa Rica, the introduction of the Nanox.ARC could mean improved diagnostic capabilities at a lower cost, potentially reducing the need for patients to travel abroad for advanced imaging. It also represents a step toward more equitable healthcare delivery in the region. For Nanox, successful deployment in Costa Rica could serve as a proof point for other markets in Central America and beyond, demonstrating the viability of its model in diverse healthcare environments. The agreement comes as Nanox continues to seek regulatory clearances and commercial partnerships worldwide, aiming to lower barriers to adoption, improve utilization, and advance preventive care globally. Investors and industry observers will be watching to see how quickly the registration process progresses and whether the proof-of-concept period leads to full-scale adoption within the CCSS system. For more details, see the full press release at https://ibn.fm/C77lJ. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX.
